Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pralatrexate in Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder
NCT00722553Phase 2Completed
- Sponsor
- Acrotech Biopharma Inc
- Start
- Jul 2008
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of pralatrexate in transitional cell carcinoma of the bladder (TCC), sponsored by Acrotech Biopharma Inc. Started Jul 2008; status: completed.
02
Drugs
pralatrexate
03
Conditions
transitional cell carcinoma of the bladder (TCC)
Beyond the preview
Go deeper on NCT00722553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00722553.